Copyright
©The Author(s) 2025.
World J Stem Cells. Jul 26, 2025; 17(7): 107153
Published online Jul 26, 2025. doi: 10.4252/wjsc.v17.i7.107153
Published online Jul 26, 2025. doi: 10.4252/wjsc.v17.i7.107153
Table 2 A Summary of the investigations and diagnostic methods for cytomegalovirus retinitis.
Investigation | Findings and utility |
Comprehensive ophthalmic examination | Central to diagnosis, identifies characteristic retinal lesions; limited by media opacity (e.g., vitritis)[21] |
OCT | Retinal thickening, hyperreflective necrotic lesions (early); retinal thinning, atrophy, photoreceptor, and RPE disruption (late); detects macular involvement[23,24] |
FAF | Hypoautofluorescence in necrotic retina; hyperautofluorescent borders indicate active inflammation[25]; ultra-widefield FAF helps assess peripheral involvement[26] |
FA | Retinal ischemia, vascular leakage, capillary dropout, telangiectasia; aids in disease monitoring[1] |
Serial retinal photography | Tracks disease progression, recurrence, and treatment response; useful in pediatric patients where direct examination is challenging[21] |
Visual field testing | Detects scotomas correlating with retinal damage; useful for assessing functional impact of CMV retinitis; requires patient cooperation[1] |
PCR for CMV DNA | Highly sensitive and specific for CMV detection in ocular fluids (aqueous/vitreous) and blood; useful in immunocompromised patients[1,27-29] |
CMV-specific antibodies | Supportive but less specific in immunosuppressed patients; potential role of tear fluid antibody levels in monitoring disease activity[30] |
- Citation: Al-Battashy A, Al-Farsi N. When hematology meets ophthalmology: Cytomegalovirus retinitis in pediatric stem cell recipients. World J Stem Cells 2025; 17(7): 107153
- URL: https://www.wjgnet.com/1948-0210/full/v17/i7/107153.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i7.107153